Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Rhea-AI Summary

Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal, orthopedic, and woundcare disorders, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference.

CEO Sean Browne and CFO Scott Neils will represent the company at the conference, which takes place September 8-10, 2025, in New York and virtually. The company's presentation will be available on-demand starting September 5 at 7:00 A.M. ET. Management will also conduct virtual one-on-one meetings with investors on September 8th.

News Market Reaction – XTNT

-3.47%

1 alert

-3.47% News Effect

-$3M Valuation Impact

$80M Market Cap

0.9x Rel. Volume

On the day this news was published, XTNT declined 3.47%, reflecting a moderate negative market reaction. This price movement removed approximately $3M from the company's valuation, bringing the market cap to $80M at that time.

Data tracked by StockTitan Argus on the day of publication.

BELGRADE, Mont., Sept. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that Sean Browne, CEO, and Scott Neils, CFO, will be participating in the H.C. Wainwright 27th Annual Global Investment Conference, which is being held September 8-10, 2025, in New York and virtually.

A company presentation will be available on demand here as of Friday, September 5 at 7:00 A.M. (ET). In addition, Xtant's management team will be available for virtual one-on-one meetings on September 8th. Interested investors should contact their representative at H.C. Wainwright. A replay of the presentation will be posted to the Presentation & Events page of Xtant's Investors website for 90 days.

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference-302546574.html

SOURCE Xtant Medical Holdings, Inc.

FAQ

When is Xtant Medical (XTNT) presenting at the H.C. Wainwright Conference 2025?

Xtant Medical's presentation will be available on-demand starting September 5, 2025, at 7:00 A.M. ET. The conference runs from September 8-10, 2025.

Who will represent Xtant Medical at the H.C. Wainwright Conference?

CEO Sean Browne and CFO Scott Neils will represent Xtant Medical at the conference.

How can investors access Xtant Medical's H.C. Wainwright Conference presentation?

The presentation will be available on-demand through the conference platform and will be posted to the Presentation & Events page of Xtant's Investors website for 90 days.

How can investors schedule meetings with Xtant Medical management?

Investors interested in one-on-one meetings with management on September 8th should contact their H.C. Wainwright representative to schedule.